Clinical Trial Update: A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current Therapy [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated whether adding BI 655130 to patients' TNF inhibitor therapy improves bowel inflammation in mild to moderate ulcerative colitis; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• BI 655130

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Colitis, Ulcerative | Phase 2 | Status: COMPLETED | Results posted: 2021-10-07